The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase 2 trial of the combination of vincristine and irinotecan with or without temozolomide, in children and adults with refractory or relapsed rhabdomyosarcoma (RMS).
 
Anne Sophie Defachelles
No Relationships to Disclose
 
Emilie Bogart
No Relationships to Disclose
 
Michela Casanova
Consulting or Advisory Role - Bayer; Halozyme; Lilly; Merck; Roche; SERVIER; Tesaro
 
Hans Merks
No Relationships to Disclose
 
Gianni Bisogno
Consulting or Advisory Role - Clinigen Group; Roche/Genentech
Speakers' Bureau - Merck
Travel, Accommodations, Expenses - Jazz Pharmaceuticals
 
Giuseppina Calareso
No Relationships to Disclose
 
Soledad Gallego Melcon
Consulting or Advisory Role - Clinigen Group; EUSA Pharma; IQvia; Loxo
Travel, Accommodations, Expenses - Loxo
 
Susanne Gatz
No Relationships to Disclose
 
Marie-Cecile Le Deley
No Relationships to Disclose
 
Kieran McHugh
No Relationships to Disclose
 
Alicia Probst
No Relationships to Disclose
 
Nathalie Rocourt
No Relationships to Disclose
 
Rick R. van Rijn
Research Funding - Roche Pharma AG (Inst)
 
Keith Wheatley
No Relationships to Disclose
 
Veronique Minard-Colin
No Relationships to Disclose
 
Julia Chisholm
Consulting or Advisory Role - Bayer; Roche; Roche/Genentech